Medicine and Dentistry
Adverse Event
17%
Alginic Acid
20%
Aneurysm
20%
Angiogenesis
32%
Bone Marrow Derived Mesenchymal Stem Cell
20%
Cancer
22%
Cell Therapy
85%
Clinical Study
30%
Coronary Artery Disease
20%
Cytokine
20%
Drug Megadose
20%
Endothelial Cell
24%
Engraftment
20%
Finger
41%
Ganglioglioma
61%
Gene Targeting
20%
Gene Transfer
20%
Heart Failure
100%
Heart Left Ventricle Ejection Fraction
22%
Heart Left Ventricle Filling Pressure
41%
Heart Muscle Ischemia
23%
Heart Ventricle Enddiastolic Pressure
20%
Heart Ventricle Function
23%
Infarction
49%
Infusion
19%
Ischemic Cardiomyopathy
46%
Low Density Lipoprotein Cholesterol
20%
Low-Density Lipoprotein
20%
Magnetic Resonance Imaging
37%
Mesenchymal Stem Cell
59%
Meta-Analysis
20%
Mononuclear Cell
41%
Myocardial Infarction
83%
Nanofiber
20%
Neoplasm
20%
Percutaneous Coronary Intervention
23%
Percutaneous Intervention
20%
Photoelectric Plethysmography
41%
Placebo
21%
Return of Spontaneous Circulation
20%
Revascularization
20%
Saphenous Vein Graft
20%
Scatter Factor
41%
ST Elevation
20%
ST Segment Elevation Myocardial Infarction
37%
Stem Cell
91%
Stent Underexpansion
20%
Systematic Review
20%
Unstable Angina Pectoris
20%
Valsalva Maneuver
41%
Keyphrases
Bone Marrow Mononuclear Cells
41%
Cardiac Regeneration
23%
Cell Potency
27%
Cell Therapy
44%
Cell-based
29%
Chemokine Ligand 12 (CXCL12)
20%
Clinical Outcomes
25%
Clopidogrel Resistance
20%
Coronary Artery Disease
20%
End-diastolic Pressure
20%
Engraftment
20%
Finger Photoplethysmography
41%
Functional Benefit
20%
Heart Failure
50%
Heart Failure Patients
20%
Heart Failure Trials
25%
High Dose
20%
Human Glioblastoma
20%
Ischemic Cardiomyopathy
27%
Ischemic Heart Failure
20%
Left Anterior Descending Artery
20%
Left Ventricular Filling Pressure
41%
Low-density Lipoprotein
20%
Low-density Lipoprotein Cholesterol (LDL-C)
20%
Mesenchymal Stem Cells
31%
Meta-analysis
20%
Non-invasive Device
20%
Paracrine Factors
20%
Percutaneous Intervention
20%
Pivotal Trial
30%
Point-of-care
20%
Post-infarct Heart Failure
30%
Prasugrel
20%
Randomized Trial
20%
Return of Spontaneous Circulation
20%
Roll-in
20%
Saphenous Vein Graft Aneurysm
20%
Scattering Factor
41%
ST Elevation
20%
ST-elevation Myocardial Infarction (STEMI)
37%
Stem Cell Bioreactors
20%
Stem Cell Delivery
20%
Stem Cell Potency
20%
Stem Cells
20%
Stent
20%
Subacute Stent Thrombosis
20%
Therapy System
20%
Transendocardial Injection
30%
Tumorigenicity
20%
Valsalva Maneuver
41%
